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Abstract
Using a computational model, we simulated mitochondrial deoxynucleotide metabolism and mitochondrial DNA
replication. Our results indicate that the output from the mitochondrial salvage enzymes alone is inadequate to support
a mitochondrial DNA replication duration of as long as 10 hours. We find that an external source of deoxyribonucleoside
diphosphates or triphosphates (dNTPs), in addition to those supplied by mitochondrial salvage, is essential for the
replication of mitochondrial DNA to complete in the experimentally observed duration of approximately 1 to 2 hours. For
meeting a relatively fast replication target of 2 hours, almost two-thirds of the dNTP requirements had to be externally
supplied as either deoxyribonucleoside di- or triphosphates, at about equal rates for all four dNTPs. Added
monophosphates did not suffice. However, for a replication target of 10 hours, mitochondrial salvage was able to provide
for most, but not all, of the total substrate requirements. Still, additional dGTPs and dATPs had to be supplied. Our analysis
of the enzyme kinetics also revealed that the majority of enzymes of this pathway prefer substrates that are not precursors
(canonical deoxyribonucleosides and deoxyribonucleotides) for mitochondrial DNA replication, such as phosphorylated
ribonucleotides, instead of the corresponding deoxyribonucleotides. The kinetic constants for reactions between
mitochondrial salvage enzymes and deoxyribonucleotide substrates are physiologically unreasonable for achieving
efficient catalysis with the expected in situ concentrations of deoxyribonucleotides.
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Introduction
Mitochondrial DNA (mtDNA) replication [1], and the mito-
chondrial nucleoside salvage pathway that generates the precursor
deoxyribonucleoside triphosphates (dNTPs) for mitochondrial
DNA replication, have generally been believed to function
independently of nuclear DNA (nDNA) replication and cytoplas-
mic nucleotide metabolism. However, the observation associating
mutated RRM2B (a p53 inducible ribonucleotide reductase
subunit) with mtDNA depletion and at least one observation of
mtDNA replication restricted to S phase in DGUOK (deoxygua-
nosine kinase) deficient cells now make it clear that mtDNA
replication and maintenance are not always completely indepen-
dent of the cytoplasmic state [2,3]. Older evidence supported the
view that mitochondrial nucleotides may be isolated from the
corresponding cytoplasmic pools [4], but more recent studies
support a metabolic cross-talk between the mitochondria and the
cytoplasm and show that nucleotide import from the cytosol very
likely contributes to mitochondrial dNTP pools in both cycling
and quiescent cells [5,6]. The mechanism of this import is
unknown since the discovery that the carrier SLC25A19 (solute
carrier family 25, member 19) actually is a thiamine pyrophos-
phate transporter and not a deoxyribonucleotide transporter [7].
Similarly, the mitochondrial monophosphate kinases of dG and T
deoxyribonucleotides (key elements of the purported salvage
pathway) still have not been identified. In the current picture of
the mitochondrial nucleoside salvage pathway, DGUOK and
TK2 (thymidine kinase 2) are the nucleoside kinases; NT5M
(mitochondrial 59,39-nucleotidase) is a nucleotidase; CMPK2
(cytidine monophosphate kinase 2), and isoforms of adenylate
kinase (AK) are the monophosphate kinases; and NME4 is the
major nucleoside diphosphate kinase (Figure 1A). Deoxyribonu-
cleosides (dNs) are converted to dNTPs through three sequential
enzyme-catalyzed phosphorylations. This is a complex process
with some reactions occurring in parallel for the four deoxyr-
ibonucleosides, and some reactions using the same enzyme (for
example, the first phosphorylation of dT and dC are both
catalyzed by TK2) in addition to the presence (not shown in
Figure 1A) of feedback mechanisms (for example, dTTP and
dCTP inhibition on TK2 [8]).
The physical structure of the mitochondrion provides another
complication that is rarely considered in this context. The
mitochondrion has an intermembrane space (between the inner
and outer membranes) and a matrix compartment within the inner
membrane (Figure 1B). Several contact sites exist between the
inner and outer membranes. In addition to the mitochondrial
enzymes listed in Figure 1A, the cytoplasmic enzymes Thymidine
Phosphorylase (TYMP) and RRM2B are included in the diagram
PLoS Computational Biology | www.ploscompbiol.org 1 August 2011 | Volume 7 | Issue 8 | e1002078since mutations in these two enzymes are known to cause
phenotypes involving defects in mtDNA maintenance [2,9]. The
mtDNA are tethered to the inside of the inner membrane, within
the matrix, so it would be expected that the enzymes of the salvage
pathway would also be located within the matrix. In the simplest
picture of the mitochondrial salvage pathway deoxyribonucleo-
sides are transported through the inner membrane by the ENT
(equilibrative nucleoside transporter) and then phosphorylated to
dNTPs within the matrix. However, evidence exists to suggest that
the AK2 adenylate kinase as well as NME4 nucleoside
diphosphate kinase might actually be localized to the mitochon-
drial intermembrane space [10,11], not in the matrix. It is possible
that other isoforms of these enzymes might localize to the
mitochondrial matrix [10,11]. If not, it is hard to understand how
the salvage pathway would function without an unnecessarily
complicated transport of deoxyribonucleotides back and forth
across the inner membrane (arrows marked with question marks in
Figure 1B).
In this paper we analyze the experimentally measured enzyme
kinetics of these known enzymes of this pathway. Our analysis of
the mitochondrial nucleotide metabolism pathway reveals that the
majority of the enzymes of this pathway are not particularly
effective in the synthesis of mtDNA precursors (phosphorylated
deoxyribonucleosides) either due to the affinities of the enzymes
for ribonucleotides and other non-DNA precursors (dI and dUMP
for example) or due to a disparity in their affinities for
deoxyribonucleotides versus the expected mitochondrial concen-
trations of those deoxyribonucleotide substrates. Computational
simulations of the function of this pathway support our analysis
and indicate that a source of deoxyribonucleotides in addition to
those provided by mitochondrial salvage is essential to account for
the experimentally observed mtDNA replication duration of 1 to
2 hours in cycling cells.
Methods
As far as possible, we restricted our analysis to data from hu-
man enzymes. Exceptions are noted below. We assumed
Michaelis-Menten kinetics for all enzymes except TK2 which
has negatively cooperative kinetics with Hill coefficient less than 1
with thymidine [8].
kcat/Km
Km values were obtained from the literature
[8,12,13,14,15,16,17,18,19,20,21,22] or the BRENDA database
[23]. For most enzymes, we could only find a single report of
kinetic parameters. For the nucleoside kinases DGUOK and TK2,
we did find multiple reports of kinetic parameters. In these cases,
we selected the reference providing the most comprehensive
information. To compute kcat values, we first obtained reported
Vmax values [8,12,14,15,16,18,19,20,21,22] and molecular weights
[13,22,23,24] of the various enzymes from the literature or the
BRENDA database. If the enzyme was reported to be a multimer,
we added the molecular weights of the subunits to calculate the
molecular weight of the holoenzyme. The quantity kcat/Km
(M
21 s
21) was calculated from the reported values of Vmax/Km
(with units of mmol min
21 mg
21 mM
21) using the following
conversion,
Kcat
Km
~
V max
Km
(Wenzyme)
106
60
  
where Wenzyme is the enzyme molecular weight. Reported values
for Km,V max, and the calculated kcat/Km values are provided in
Table S1.
Substrate Concentrations
Values for the concentrations of the deoxyribonucleoside,
deoxyribonucleotide, ribonucleoside, and ribonucleotide substrates
were used to calculate ‘(substrate) Concentration/(substrate) Km’
ratios. These values were used for a comparison of activities of the
enzyme with different substrates and are not meant to be precise.
Instead, rough order-of-magnitude concentration values were used
to compare values for this ratio, which often varies by several
orders of magnitude within a single enzyme for different
substrates. Literature reports suggested that mitochondrial dNTP
pools are higher in actively cycling cells compared to quiescent
cells [25,26,27,28]. We assumed a 10-fold lower concentration of
deoxyribonucleotides in quiescent cells, and chose 10 mM and
1 mM as reasonable representative estimates of mitochondrial
dNTP concentrations in cycling and quiescent cells respectively.
The basis of these estimates are the concentrations calculated from
published values in HeLa cells [29] and quiescent fibroblasts [30]
respectively. We used a value of 0.82 ml/g mitochondrial protein
[31] to calculate concentrations from the measured pool sizes in
HeLa cells, and we used the value of 92.3 mm
3 for mitochondrial
volume per cell [32] to obtain the concentrations from the
measured pool size in quiescent fibroblasts. For simplicity, we
assumed ribonucleotides and deoxyribonucleotides to be equally
concentrated in the three phosphorylation states (mono, di, or tri-
phosphorylated). Again for simplicity we assumed all four
nucleotides (dAXP, dCXP, dGXP, dTXP where X=phosphor-
ylation state) to have equal concentrations. Nucleoside concentra-
tions were assumed to be equilibrated between plasma, cytoplasm,
and mitochondria and set at a constant 0.5 mM using a reported
value for plasma concentration [33]. Lower nucleoside concen-
trations have also recently been reported [34,35]. We have kept
the higher value in our analysis since this is the most conservative
choice. Lower nucleoside concentration values would make the
problems that we point out in this analysis even more severe.
Ribonucleotide concentrations were assumed to be constant and
Author Summary
The powerhouses of human cells, mitochondria, contain
DNA that is distinct from the primary genome, the DNA in
the nucleus of cells. The mitochondrial genome needs to
be replicated often to ensure continued generation of ATP
(adenosine triphosphate) which is the energy currency of
the cell. Problems with maintenance of mitochondrial
DNA, arising from genetic mutations as well as from
antiviral drugs, can lead to debilitating diseases that are
often fatal in early life and childhood, or reduced
compliance to therapy from patients suffering drug
toxicity. It is therefore important to understand the
processes that contribute to the upkeep of mitochondrial
DNA. The activities of a set of enzymes, which together
generate the chemical building blocks of mitochondrial
DNA, are important in this regard. We used computational
methods to analyze the properties of these enzymes.
Results from our approach of treating these enzymes as a
system rather than studying them one at a time suggest
that in most conditions, the activities of the enzymes are
not sufficient for completing replication of mitochondrial
DNA in the observed duration of around 2 hours. We
propose that a source of building blocks in addition to this
set of enzymes appears to be essential.
Mitochondrial Salvage Pathway Kinetics
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cells and two orders of magnitude higher in quiescent cells
compared to deoxyribonucleotide concentrations. This is a fairly
conservative (i.e. low) choice for the ribonucleotide concentrations.
For other special cases of substrates (such as dUMP, dI, or IMP)
concentrations data are not readily available so we again assumed
low concentration values for these substrates. The complete list of
assumed concentrations is provided in Table S1.
Inhibitions
In the case that we could not find Ki values of for enzyme
inhibitors, we assumed competitive inhibition so that the Ki for the
Figure 1. Mitochondrial deoxyribonucleoside salvage metabolism. (A) Biochemical pathway representation of the mitochondrial
deoxyribonucleoside salvage metabolism. Deoxyribonucleosides undergo a series of reversible phosphorylations to become deoxyribonucleoside
triphosphates (substrates for mtDNA replication). Enzymes that are yet to be identified are represented by question marks. (B) Subcellular
localizations of some enzymes important for the production of intra-mitochondrial dNTPs. Arrows denote the flow of substrates between the
enzymes. The question marks denote substrate flows that appear to be required by the enzyme localization data, but which seem unreasonable.
doi:10.1371/journal.pcbi.1002078.g001
Mitochondrial Salvage Pathway Kinetics
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substrate. Inhibition kinetics data [8,12,16,19,21,22,36] are
provided in Table S1.
Computational Simulations
Our group has previously published a computational model of
mitochondrial deoxyribonucleotide metabolism [25]. Parameter
values for the model were based, whenever available, on published
experimental values [8,12,14,16,17,19,20,21,22,23,24,25,36,37,
38,39,40,41,42,43]. As part of the present work, we updated the
model to reflect the findings since the original model was defined.
We refer the readers to the previous publication for a complete
explanation of the basic framework of the model [25]. Briefly,
enzymatic reactions were modeled with Michaelis-Menten equa-
tions (except TK2, which is modeled by the Hill equation) and
rates of change of metabolites were modeled using ordinary
differential equations. The updates to the model include adding
(e.g. CMPK2) and removing (e.g. SLC25A19 or DNC) pathway
components and updated kinetics (e.g. inhibition terms and kinetic
constants). The model was written in Mathematica 7. The model
files are available as supporting information (Text S1). The model
constants are also available as supporting information in plain text
(Text S2) and PDF (Text S3).
Deoxynucleoside transport was modeled through the ENT
protein as equilibrative between the cytoplasm and mitochondria.
Thus, the net rate of deoxynucleoside transport was defined using
the Michaelis-Menten equation as follows:
VENT, j~
V max, j½dN cyto, j
Km, j 1z
X
i
½Ci 
Ki, i
 !
z½dN cyto, j
{
V max, j½dN mito, j
Km, j 1z
X
i
½Ci 
Ki, i
 !
z½dN mito, j
where j represents the four deoxynucleoside species (dA, dC, dG,
dT) and i represents inhibitors. Vmax and Km were taken to be the
same for both directions of transport.
The various enzymatic reactions (i.e., phosphorylations and
dephosphorylations) were modeled using the Michaelis-Menten
equation. Thus, the reaction velocity was
V~
V max½S 
Km 1z
X
i
½Ci 
KI, i
 !
z½S 
where S stands for substrate and [C] stand for the concentration of
any competitive inhibitors. For the reaction of dT with TK2, the
above equation was modified by raising the Km and [S] terms to
the power 0.5 to represent the Hill coefficient.
The model of the mtDNA polymerization process was explained
in the previous publication [25]. It models polymerization using
fractions of the four deoxynucleotides in the mtDNA sequence,
setting the prevalence of each base in the mtDNA light and heavy
strands separately to match the prevalence in the rCRS reference
sequence [44]. We have modeled mtDNA replication as
asynchronous [45] using the locations of the origins of replication
of the light strand and the heavy strand.
Differential equations for the concentrations of the various
metabolites were defined by adding and subtracting the relevant
reaction velocity equations. For example, for dNMPs (deoxyr-
ibonucleoside monophosphates), the following differential equa-
tion models the rate of change of a particular dNMP:
d½dNMPj 
dt
~NKj{NTjzNMPKrev, j{NMPKfwd, j
where NK represents the nucleoside kinase reaction, NT
represents the nucleotidase reaction, NMPK represents the
forward and reverse monophosphate kinase reactions. The kinetic
constants and inhibition parameter values are available in Table
S1.
We used this updated model to test the hypothesis that a source
of deoxyribonucleotides in addition to intra-mitochondrial salvage
is essential for completing mtDNA replication in cycling cells in
the experimentally observed time of 1–2 hours [45]. To be
conservative, we set the ‘target’ replication time to be 2 hours
(requiring an average replication rate=33136 (nucleotides)/120
(minutes)=,276 nucleotides/minute). We ran simulations with a
simulation time of 120 minutes (2 hours), with all dynamics
including mtDNA replication starting immediately at the begin-
ning of the simulation. We also tested a target replication time of
10 hours (requiring an average replication rate=33136 (nucleo-
tides)/600 (minutes)=,55 nucleotides/minute) – reasoning that
in quiescent cells the time constraints for completing mtDNA
replication may be more relaxed.
Transport of deoxynucleotides from the cytoplasm to the
mitochondrial matrix was modeled in a simple manner, by setting
a constant production term of either deoxynucleosides, dNMPs,
dNDPs (deoxyribonucleoside diphosphates), or dNTPs. Transport
was modeled as occurring at only one phosphorylation level at a
time, in order to assess the effectiveness of transport at each level.
The essence of our simulation experiments was to test whether
mtDNA replication was completed in the target time under
varying levels of added molecules, including no addition, of
various (A, C, G, T) deoxynucleosides and deoxynucleotides. We
note that in principle the additional source of deoxynucleotides in
this model does not necessarily have to be import from the
cytoplasm, but could also be from other unknown intra-
mitochondrial sources. However, considering the evidence that
nucleotide transport does occur between the cytoplasm and
mitochondria [5,6], we assume that the additional source we have
modeled corresponds to import from the cytoplasm. We tested
multiple ‘transport profiles’. A transport profile is composed of
simply the rate of the transported deoxynucleosides and
deoxynucleotides. For each transport profile, we ran 100
simulations each beginning with a different, randomly selected
(with uniform probability) set of initial mitochondrial concentra-
tions of each deoxynucleoside and deoxynucleotide. As an initial
test of the level of exogenous precursor transport needed, we set
equal rates of import for all four (A, C, G, T) nucleosides (or
nucleotides) at a particular phosphorylation level and then let the
rate of import vary from 0 to 1200 molecules per minute, in
increments of 100. Thus, for example, for testing whether
transport of deoxynucleosides alone suffices, we ran 13 sets of
100 simulations. In each of those 13 sets, deoxynucleosides alone
were imported at equal rates for each of the four nucleosides, in
increments of 100 starting from 0 and up to 1200. Such simulation
sets of 13 different import levels were conducted similarly for each
phosphorylation level of the four deoxynucleoside species.
The initial conditions of the simulations were set randomly with
a uniform distribution over a set range. The allowed range (mini-
mum and maximum) of initial deoxynucleoside concentrations was
Mitochondrial Salvage Pathway Kinetics
PLoS Computational Biology | www.ploscompbiol.org 4 August 2011 | Volume 7 | Issue 8 | e10020780.05 mMt o5 mM and the range of initial deoxynucleotide
concentrations was 0.1 mMt o1 0 mM. We set the concentra-
tions of ribonucleosides, ribonucleotides, and non-canonical
deoxynucleosides and deoxynucleotides to be proportional to the
randomly selected dN and dNXP concentrations (see Table S1 for
details), and held these concentrations (which only acted as
inhibitors) constant throughout the time course of the simulation.
The simulations were repeated 100 times with varying initial
conditions.
We extended the transport analysis further by obtaining the
minimum number of molecules of each transported dNTP
required for mtDNA replication to be completed in 2 hours
(representing cycling cells) or 10 hours (representing quiescent
cells). For the simulations to determine the minimum transport
profiles, we tested whether the replication rate exceeded 55
(‘quiescent cells’, fixed initial concentrations: dNs=0.5 micromo-
lar and dNXPs=1 micromolar) or 276 (‘cycling cells’, fixed initial
concentrations: dNs=0.5 micromolar and dNXPs=10 micromo-
lar) nucleotides per minute. We started at equal import of all four
dNTPs at a rate such that replication would be completed in
slightly less than the target time (2 hours or 10 hours). Next, we
decreased the import of one dNTP at a time to check whether the
target replication rate was observed. We continued this relaxation
process until we obtained the minimum transport for each
individual deoxyribonucleotide species necessary to support the
target replication rate.
Results
The kcat/Km Ratio
In Michaelis-Menten kinetics, kcat and Km are the basic
parameters of an enzyme-substrate reaction pair. The parameter
kcat is the number of substrate molecules catalyzed per enzyme
molecule per unit time and Km is the substrate concentration at
which the reaction proceeds at half-maximal velocity. High kcat
and low Km values imply a fast and efficient reaction, and thus, a
high kcat/Km ratio indicate that this substrate is catalytically
preferred by the enzyme. We searched the literature
[8,12,13,14,15,16,17,18,19,20,21,22] and databases [23] and
gathered the available data on the reaction kinetics of enzymes
of mitochondrial nucleotide salvage. Figure 2A shows a plot of
kcat/Km values. Each group of bars is for one enzyme, and within
each group the bars are arranged from lowest to highest so that the
best substrates lie to the right on each plot. For clarity, the
substrates that are DNA precursors (presumed to the ‘proper’
substrates of these enzymes) are in green, and non-DNA precursor
substrates are in red. The kcat/Km values cover a very wide range
and so are plotted on a logarithmic scale.
Figure 2A shows that each of these enzymes has significant
reactions with non-DNA precursors. More importantly, except for
TK2, none of the mitochondrial enzymes have DNA precursors as
their preferred substrates, as seen from the fact that the substrates
which lie to the right in each group of bars are non-DNA
precursors. Prior work [46] has estimated the theoretical
maximum of kcat/Km for an enzyme-substrate pair. This
maximum is constrained by the diffusion limit, and was estimated
to be ,10
8 per M per second [46]. Compared to the diffusion
limit, the kcat/Km values for reactions of the mitochondrial salvage
pathway with DNA precursors are orders of magnitude lower
(range=888 to 5.63610
5 per M per second). In summary, in both
absolute and relative terms these enzymes of the mitochondrial
salvage pathway (with the possible exception of TK2) do not
appear to be optimized for discriminating mtDNA precursor
substrates from chemically related non-precursor substrates.
To put the kcat/Km results in Figure 2A in perspective,
Figure 2B is a plot of kcat/Km for the various substrates of the
mitochondrial DNA polymerase gamma (POLG). In contrast to
the enzymes of mitochondrial nucleotide metabolism, Figure 2B
shows that, as expected, DNA precursors are preferably
discriminated by POLG. This is true both absolutely and
relatively. The kcat/Km values for the dNTP substrates approach
the diffusion limit of ,10
8 per M per s, and the values for dNTP
substrates are many orders of magnitude larger than the kcat/Km
values of the ribonucleotide substrates. GTP and UTP kinetics
data are not shown because the POLG kinetics with these
potential substrates have not been measured.
The Effects of Substrate Concentration
While the ratio kcat/Km captures the efficiency of a reaction
between an enzyme and a substrate, it does not take into account
the expected physiological concentration of the substrate, which
may vary by several orders of magnitude between ribonucleotide
and deoxyribonucleotide substrates. The ratio of ‘(substrate)
Concentration/(substrate) Km’ provides information that is
complementary to that revealed in the previous section by the
ratio kcat/Km. When the substrate concentration is much smaller
compared to the Km, the enzyme is sensitive to substrate
concentration and can thus operate at a range of velocities.
However, the velocities in this range would be smaller than the
maximum possible velocity. Depending on the relation between
maximum possible velocity and the required rate of enzymatic
output, substrate concentrations smaller than Km can be a
detriment. This is the case for the mitochondrial salvage enzymes
because mtDNA replication has to satisfy certain time constraints.
We searched the literature [8,12,13,14,15,16,17,18,19,20,21,22]
and databases [23] for Km values of the mitochondrial salvage
enzymes for various substrates and their expected in situ
concentrations. Figures 3A and 4A show a plot of Concentra-
tion/Km values for all of the enzyme-substrate pairs for which we
could find data. As before, each group of bars is for one enzyme,
and within each such group the bars are arranged from lowest to
highest value of the ratio. Preferred substrates would be expected
to have higher concentrations relative to the reaction Km and thus
would fall to the right in each enzyme. Substrates that are DNA
precursors are plotted in green, and non-DNA precursor
substrates are in red.
Figure 3A shows Concentration/Km values at higher mito-
chondrial concentrations (‘cycling cells’) of the deoxyribonucleo-
tide substrates (10 mM). The Concentration/Km values for DNA
precursor substrates range from 0.001 to 0.19. Thus, none of the
reactions involving DNA precursor metabolism in the mitochon-
dria would be running at maximal reaction velocity. In fact, since
all reactions involving DNA precursor substrates have Concen-
tration/Km values less than 1, none of these reactions would be
expected to be running at even half-maximal velocity. It is
apparent that these enzymes of mitochondrial nucleotide metab-
olism have significant affinities for non-DNA precursors. In many
cases, the enzymes have higher affinities for non-DNA precursors
than for the DNA precursors. In the case of the nucleoside kinases
TK2 and DGUOK, although they have higher affinities for DNA-
precursors, there is less than 10-fold difference from their
preference of non-DNA precursors. For some reactions, the
expected substrate concentrations are orders of magnitude lower
than the reaction Km values (range: 0.001 to 0.19). The same
trends exist in the values of Concentration/Km assuming lower
mitochondrial concentrations of substrates (Figure 4A). Moreover,
comparing Figure 4A (low deoxyribonucleotide concentrations) to
Figure 3A (high deoxyribonucleotide concentrations), the disparity
Mitochondrial Salvage Pathway Kinetics
PLoS Computational Biology | www.ploscompbiol.org 5 August 2011 | Volume 7 | Issue 8 | e1002078Figure 2. kcat/Km values of mitochondrial enzymes. (A)k cat/Km values of mitochondrial salvage enzymes. Each group of bars is for one enzyme,
and within each such group the bars are arranged from lowest to highest so that the best substrates lie to the right on each plot. Substrates that are
DNA precursors are in green, and non-DNA precursor substrates are in red. 29-UMP and 39-UMP refer to uridine 29 monophosphate and uridine 39
monophosphate. (B)k cat/Km values of the mitochondrial DNA polymerase POLG, justifying the use of kcat/Km as a measure of substrate preference.
doi:10.1371/journal.pcbi.1002078.g002
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PLoS Computational Biology | www.ploscompbiol.org 6 August 2011 | Volume 7 | Issue 8 | e1002078Figure 3. Concentration/Km values in ‘cycling cells’ for mitochondrial enzymes. Concentration/Km values at higher mitochondrial
concentrations (‘cycling cells’) of the deoxyribonucleotide substrates (10 mM). (A) Values for mitochondrial salvage enzymes. All reactions involving
DNA precursor substrates have Concentration/Km values less than 1, suggesting that none of these reactions would be expected to be running at
even half-maximal velocity. (B) Values for POLG and SLC25A19, justifying the principle of using the ratio Concentration/Km as a measure of substrate
preference. The Concentration/Km ratio for dNTP substrates for POLG is about an order of magnitude larger than the ratios for reactions with rNTPs.
The Concentration/Km ratios of DNA precursor substrates of SLC25A19 are low.
doi:10.1371/journal.pcbi.1002078.g003
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with an order of magnitude decrease in the Concentration/Km
ratio of the DNA precursor substrates (range: 0.0007 to 0.19). This
was expected as we assumed mitochondrial ribonucleotide
concentrations to be constant and independent of high or low
mitochondrial deoxyribonucleotide concentrations.
To place these enzyme kinetics values in context Figures 3B and
4B show positive and negative examples justifying the principle of
Figure 4. Concentration/Km values in ‘quiescent cells’ for mitochondrial enzymes. Concentration/Km values at lower mitochondrial
concentrations (‘quiescent cells’) of the deoxyribonucleotide substrates (1 mM) for (A) mitochondrial salvage enzymes and (B) POLG and SLC25A19.
doi:10.1371/journal.pcbi.1002078.g004
Mitochondrial Salvage Pathway Kinetics
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preference. The Concentration/Km ratio for dNTP substrates for
POLG is about an order of magnitude larger than the ratios for
reactions with ribonucleoside triphosphates (rNTPs) (Figure 3B). It
is noteworthy that POLG is the only enzyme of the mitochondrial
‘salvage’ (DNA replication) pathway whose DNA precursor
substrates have expected concentrations that are larger than the
enzyme Km values. For our negative example, we considered
SLC25A19 (formerly named the deoxynucleotide carrier (DNC),
now identified as the thiamine pyrophosphate carrier) [7] to be a
suitable choice. In contrast to POLG, the Concentration/Km
ratios of DNA precursor substrates of SLC25A19 are low both in
the absolute and the relative sense. Dolce et al [13] published data
on the Km and Ki values of substrates (we used Ki as a proxy for
Km if Km was not reported) that were tested for transport by the
SLC25A19 protein, and it is seen in Figures 3B and 4B that DNA
precursor substrates (green bars) are not the preferred substrates of
this enzyme. Eventually, it was discovered that the function of
SLC25A19 had been misinterpreted [7,47]. When we compare
the concentration/Km plots of the mitochondrial nucleotide
metabolism (Figures 3A and 4A) to those of POLG and
SLC25A19 (Figures 3B and 4B) we observe that the Concentra-
tion/Km values of DNA precursors with the enzymes of
mitochondrial nucleotide metabolism are at the same level as
the Concentration/Km values of the DNA precursors with
SLC25A19, even though these DNA precursors are not the
physiological substrates of SLC25A19. We note that SLC25A19
was not used a negative example in Figure 2B because the enzyme
kinetics values (kcat) were not available for the relevant
deoxyribonucleotide or ribonucleotide substrates.
As a side observation, we are intrigued by the fact that at lower
dNTP concentrations the Concentration/Km values for rNTPs are
essentially equal to those for dNTPs for polymerization by POLG
(Figure 4B). This observation reveals that discrimination by POLG
in this case is perhaps almost completely dependent on the
corresponding reaction Vmax. As the Vmax (or kcat) of rNTPs with
POLG are much lower than those for dNTPs, it is possible that in
quiescent cells POLG faces more interference by ribonucleotides,
thus obstructing the polymerization of deoxyribonucleotides into
the DNA molecule being synthesized and at the same time
promoting the incorporation of ribonucleoside triphosphates in the
DNA strand. This is consistent with the reported incorporation of
ribonucleotides in replicating mtDNA [48].
Substrate Flow through the Salvage Pathway
As an initial analysis of the function of the salvage pathway, we
used the Michaelis-Menten equation to calculate reaction rates
under assumed substrate concentrations. We ignored the effect of
inhibitions. This implies that the reaction rates we calculated
(number of substrate molecules catalyzed per enzyme molecule per
minute) were the upper-bound of the rates at the estimated
concentrations, because inhibitions would act to lower these rates.
We call such reaction rates ‘effective velocities’. As we assumed
deoxyribonucleoside concentrations to be constant at 0.5 mM and
deoxyribonucleotide concentrations to be either 10 mM (high,
‘cycling cells’) or 1 mM (low, ‘quiescent cells’), we obtained two sets
of effective velocities for the enzymes of mitochondrial nucleotide
metabolism – one approximating the behavior in cycling cells, and
one approximating the behavior in quiescent cells.
Figure 5A is a plot of the effective velocities of nucleoside kinases
versus NT5M. Remember from Figure 1A that NT5M is the
nucleotidase that reverses the action of the nucleoside kinases, so
the amount of material fed into the salvage pathway depends in
part on the balance between these two groups of enzymes. The
substrate dCMP is absent for Figure 5A because no reaction was
observed between NT5M and dCMP [19]. Note that the
nucleoside concentrations were assumed to be constant, so the
high and low concentration rates are only given for NT5M.
Because of inhibitions and competing reactions, the deoxyribonu-
cleoside output from NT5M would be much lower than
represented here, but it is still instructive to compare objectively
the disparity between the forward and reverse reactions at the first
phosphorylation level. It is clear that the theoretical maximum
velocities (at the assumed concentrations) of NT5M reverse
reactions are many-fold higher than the maximum velocities from
nucleoside kinases. While the situation is poor for the dG and dT
substrates, it is extremely poor for the dA substrate where the
reverse reaction has well over an order of magnitude advantage
over the forward reaction. Furthermore, NT5M may not be the
only nucleotidase in the mitochondria, thus exacerbating this issue
[19].
In addition to these qualitative comparisons of substrate
preferences of mitochondrial nucleotide metabolism enzymes, we
analyzed the reaction kinetics further to approximately quantify
the flow of substrates through this enzymatic pathway. For
simplicity, we ignored the inhibition terms in the Michaelis-
Menten equations (inhibitions would further reduce reaction
velocities). We could then investigate the effect of kcat,K m, and
substrate concentrations on the upper-bound of velocity of the
reactions at assumed substrate concentrations and compare the
estimated velocities to the expected requirements for completing
one round of mtDNA replication in a specified amount of time. It
has been reported that one round of mtDNA replication in cell
culture takes ,1–2 hours to complete [45]. To be conservative,
we assumed that mtDNA replication takes 2 hours to complete.
To replicate 16,568 bases pairs on two mtDNA strands in 2 hours,
,276 nucleotides are required per minute on average (with the log
scale on Figure 5B it is unnecessary to precisely divide this quantity
into the specific numbers of dATP, dCTP, dGTP, and dTTP
molecules needed for the human mtDNA sequence). Figure 5B
shows the effective velocities of some of the enzymes of
mitochondrial nucleotide metabolism (DGUOK, TK2, CMPK2
and AK2). These are all the enzymes for which we found data that
would enable us to calculate effective velocities. To facilitate
comparison across these enzymes, some data for DGUOK and
TK2 are repeated in Figure 5B from Figure 5A. As before,
nucleoside kinase velocities in Figure 5B are the same for high or
low concentration conditions because nucleoside concentrations
are assumed to be constant. There exists a many-fold difference in
the output of the four dNMPs, with dA nucleosides being fed into
the salvage pathway by DGUOK at a rate many orders of
magnitude lower than that required to support mtDNA synthesis.
Assuming a 2 hour replication duration and an approximately
276/4 nucleotides per minute substrate requirement, the number
of molecules of the DGUOK enzyme per mitochondrion required
to catalyze the requisite output of dAMP is close to 3000. The
poor kinetics of DGUOK with dA is not the only problem with the
dA pathway. Although there could be multiple AK isoforms in the
mitochondria, some of them are reported to be lacking kinase
activity and none of them appear to catalyze dAMP phosphor-
ylation with comparable efficiency to that of AMP phosphoryla-
tion [49]. This is verified for AK2 as seen in Figures 2A, 3A, and
4A.
A calculation of dCDP production by CMPK2 at low assumed
dCMP concentrations shows that more than 1000 CMPK2
enzymes per mitochondrion would be required to produce the
necessary dCMP output per minute (assuming an approximate
requirement of 276/4 nucleotides per minute). This result is
Mitochondrial Salvage Pathway Kinetics
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in many tissues [22], thus implying that CMPK2 function may not
be essential for the production of mtDNA precursors as has been
noted previously [22].
The data on the kinetic parameters of the human mitochondrial
nucleoside diphosphate kinase (NME4 in Figure 1) is scarce (Km
for dTDP of approximately 1 mM, which is 100 to 1000 times the
physiological concentration of dTDP) [17], which is why it is not
included in Figure 5B. An NDPK isolated from the pigeon
mitochondrial matrix preferred ribonucleoside diphosphates over
deoxyribonucleoside diphosphates by several fold [42]. Surpris-
ingly, it appears that both AK2 [11] and NME4 [10] are localized
in the mitochondrial intermembrane space, thus suggesting that if
their reaction products participate in the mtDNA precursor
synthesis, they would then have to be imported into the
mitochondrial matrix. Although dAMP is not the preferred
substrate for AK2 (Figures 2A, 3A, and 4A), AK2 still has a very
fast reaction with dAMP (Figure 5B). Good efficiency with dAMP
and the localization of AK2 in the intermembrane space instead of
in the mitochondrial matrix seem to contradict each other
regarding the role of AK2 in mtDNA precursor synthesis.
Computational Simulations
To test our conclusions and to build upon them, we used an
updated computational model to perform simulations of deoxy-
ribonucleotide dynamics and mtDNA replication within the
Figure 5. Effective velocities of some of the reactions of mitochondrial nucleotide metabolism. (A) Effective velocities (number of
substrate molecules catalyzed per minute per enzyme molecule) of nucleoside kinase reactions versus NT5M reactions. Theoretical maximum
velocities of NT5M reverse reactions are many-fold higher than the maximum velocities from nucleoside kinases. (B) A comparison of the effective
velocities for deoxynucleotide substrates for enzymes of the mitochondrial salvage pathway. The horizontal reference line shows the number of
nucleotides (approximately 69) of each triphosphate needed per minute on average to complete mtDNA replication in two hours.
doi:10.1371/journal.pcbi.1002078.g005
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us to investigate the dynamics and origins of mitochondrial
dNTPs. Our modeling is based on experimentally measured
kinetics and model results enable us to quantitatively track the
concentrations as well as the balance of the various deoxynucleo-
sides and deoxynucleotides over time within an individual
mitochondrion. Furthermore, the mitochondrial salvage pathway
is complex and a systems analysis of this pathway as a whole is an
important companion to the study of the individual enzyme
kinetics.
Figure 6 shows our simulation results. The X-axis represents the
number of molecules of each nucleotide supplied to the
mitochondrion in the form of a ‘source’ term in the differential
equations in addition to the output from salvage within the
mitochondrion. Each value on the X-axis is the sum of molecules
supplied of all four species. For example, the X-axis value of 400
means that 100 molecules per minute of each of the four (A, C, G,
T) species were supplied. The Y-axis represents the average (over
120 minutes of simulation time) mtDNA replication rate that we
observed, calculated as number of nucleotides replicated divided
by the time taken to replicate them. Initial values for the substrate
concentration in the mitochondrion were randomly varied over a
set range as described in the Methods section. Each Y value
corresponds to the mean of 100 replication rates from 100
simulations with differing initial substrate conditions. The standard
deviations were far smaller than the mean values (and are
therefore not shown in Figure 6) indicating that the simulation was
not sensitive to the initial substrate conditions. We compared the
observed replication rates to those required to complete mtDNA
replication in 2 hours (‘cycling cells’) or 10 hours (‘quiescent cells’).
For the mtDNA length of 33,136 nucleotides (replicating both
strands), these would be 33136 (nucleotides)/120 (minutes) and
33136 (nucleotides)/600 (minutes) respectively or approximately
276 nucleotides per minute and 55 nucleotides per minute
respectively. Since the mean observed replication rates with no
additional nucleotides supplied (0 on the X-axis) fall below the
2 hour line, it is clear that the output from mitochondrial salvage
cannot account for an mtDNA replication duration of 2 hours. In
fact, even when a 10 hour replication target was set, mitochondrial
salvage alone is an inadequate source of dNTPs, though only a
slight amount of additional substrate supplied by transport is
needed in this case. Next, we note that both deoxynucleoside as
well as deoxynucleoside monophosphate import are insufficient to
support a 2 hour replication target. Transport of either dNDPs or
dNTPs is sufficient to achieve the target replication rate. The
profiles of dNDP and dNTP transport are indistinguishable from
one another on Figure 6 because of the extremely fast kinetics of
NME4.
Transport of approximately 48 molecules per minute for each of
the four nucleotide species was required to complete mtDNA
replication in 2 hours. The longer replication time of 10 hours
required a transport of 15 dNTP molecules per minute for each of
the four nucleotide species. These rates were determined from the
simulation by transporting all four nucleotide species at equal rates
and with fixed initial concentrations (as described in Methods).We
next addressed the question of the minimum transport of each
dNTP species necessary to support the target replication. As
described in the Methods section, the assumption of equal
transport of the four dNTP species was relaxed to find the
minimal amount of transport separately for each dNTP species
required to meet the mtDNA replication rate goal. To achieve a
replication rate of at least 276 nucleotides per minute (‘cycling
cells’), 47, 31, 48, and 48 molecules per minute of dTTP, dCTP,
dATP, and dGTP were required. Thus, for this condition of
relatively fast replication, transport of all four nucleotide species at
similar rates is necessary. The total dNTP transport rate sums to
174 nucleotides per minute, a large fraction of the 276 dNTPs per
minute consumed by the mtDNA replication. For the slower
mtDNA replication with a target of 10 hours, Figure 6 shows that
a relatively small amount of transport of dNTP molecules per
minute suffices. To achieve the replication rate target of at least 55
nucleotides per minute (representing slow mtDNA replication in
‘quiescent cells’), individual dNTP transport rates of 0, 3, 8, and 15
molecules per minute of dTTP, dCTP, dATP, and dGTP were
required. Due to the complexity of the system (a nonlinear one
because of feedbacks and inhibitions), slightly different but often
practically similar transport profiles were observed to result in
similar replication rates. For example, for cycling cells the
transport profile of 41, 34, 48, and 41 molecules per minute also
achieved the replication rate target. For quiescent cells, the profiles
of 2, 2, 8, and 15 and 0, 2, 8, and 15 molecules per minute
(practically identical to the transport profile given above) also
achieved the replication rate target.
In summary, rapid replication of mtDNA requires a substantial
additional source of all four dNTPs (or dNDPs) to supplement the
limited kinetics of the mitochondrial salvage pathway. Under the
conditions of quiescent cells, the primary requirement is for the
transport of dATP and dGTP molecules, and the vast majority of
the dNTPs consumed by the mtDNA replication can be provided
by the salvage pathway.
Discussion
Kinetic Characteristics of the Mitochondrial Salvage
Enzymes and Their Contribution in Producing dNTP
Substrates for mtDNA Replication
Based on this analysis of the enzyme kinetics three properties of
the mitochondrial nucleoside salvage pathway are thus apparent:
i) The majority of the enzymes of this pathway are not
restricted or specific for metabolism of mtDNA precursors.
ii) The majority of the characterized enzymes prefer non-DNA
precursor substrates.
iii) For the majority of substrate-enzyme pairs, the kinetic
constants are physiologically unreasonable for achieving
efficient catalysis with the expected substrate concentrations
in situ.
From the kinetics perspective mitochondrial nucleotide metab-
olism as defined by this set of enzymes (Figure 1) cannot be
expected to be the primary source of dNTP substrates for the rapid
replication of mtDNA molecules. Since ribonucleotides exist at
higher concentrations than deoxyribonucleotides, enzymes that
take both ribonucleotide and deoxyribonucleotide substrates will,
in situ, not favor the catalysis of deoxyribonucleotides. This is
certainly true for enzymes that possess higher affinities for
ribonucleotides, but also for those enzymes that have only slightly
better kinetics for deoxyribonucleotides. In these cases ribonucle-
otide substrates will simply out-compete the deoxyribonucleotides
substrates owing to the relative abundance of ribonucleotides.
The Contribution of Cytoplasmic Nucleotide Metabolism
in Producing dNTP Substrates for mtDNA Replication
One plausible interpretation of this analysis is that import of
cytoplasmic deoxyribonucleotides is the primary source that
supplies the direct precursors for the replication of mitochondrial
genome while the mitochondrial salvage pathway acts as a back-up
metabolism with a minimal role to play in cycling cells. The
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PLoS Computational Biology | www.ploscompbiol.org 11 August 2011 | Volume 7 | Issue 8 | e1002078Figure 6. The effects of nucleotide import into the mitochondrion on the mtDNA replication rate. Each point is the mean mtDNA
replication rate from 100 simulations with different randomly chosen initial concentrations of deoxynucleosides and deoxynucleotides. The X-axis
represents the total amount of additional deoxynucleosides or deoxynucleotides supplied (sum total of equal amounts for each of the four species).
Additional supply of dN, dNMP, dNDP or dNTP were simulated separately. The dNTP output from mitochondrial salvage alone is insufficient to
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chondria and cytoplasm and the substantial contribution of
cytoplasm deoxynucleotides towards intra-mitochondrial dNTP
pools have been demonstrated [5,6]. Our results make it possible
to comment on why this must be so, due to the kinetic properties
of the enzymes of mitochondrial salvage. Our results also enable us
to conclude that import of deoxyribonucleotides is in fact essential
to support an mtDNA replication time of ,2 hours. Furthermore,
simulations based on these enzyme kinetics indicate that this
import occurs either at the dNDP or dNTP level. In cells where
cytoplasmic deoxynucleotide concentrations are low, mitochon-
drial salvage would assume a greater role and, in combination with
some other supply such as RRM2B mediated reduction of
ribonucleotides in the cytoplasm followed by deoxyribonucleotide
transport into the mitochondrion, would produce the dNTPs for
both the replication of mitochondrial DNA and perhaps repair of
nuclear DNA. Possibly, the dNDPs produced by RRM2B activity
might first undergo the terminal phosphorylation by NME4 in the
intermembrane space (Figure 1B) and may then be imported into
the mitochondrion matrix at the dNTP level to combine with the
dNTP pool from intra-mitochondrial salvage. Indeed, this is
consistent with defects in the mitochondrial salvage pathway
having their most severe phenotype in post-mitotic tissues. That
mitochondrial salvage has only a back-up role in supporting
mtDNA replication is one explanation why DGUOK and TK2
deficiency phenotypes are tissue-restricted and not systemic.
Similarities and Differences between Nucleotide
Metabolism in the Cytoplasm and Mitochondria
The kinetic characteristics of the cytoplasmic counterparts of
mitochondrial salvage enzymes expose informative parallels and
distinctions between the cytoplasmic and mitochondrial pathways
of nucleotide metabolism. The good activity of the mitochondrial
enzymes (except the nucleoside kinases TK2 and DGUOK) with
ribonucleotide substrates implies that these enzymes might play as
important a role in ribonucleotide production to support RNA
synthesis as they do in supporting DNA synthesis. Based on our
analysis, we would argue that future studies of the kinetics of the
mitochondrial salvage enzymes would benefit from a broader
characterization of the kinetics, particularly the activity of the
enzymes with ribonucleotide substrates relative to the activity with
deoxyribonucleotide substrates. The majority of the cytoplasmic
counterparts also show a preference for non-DNA precursors (such
as dUMP) and ribonucleotide substrates [12,43,50]. However, the
role of nucleoside salvage as a source of dNTPs for nuclear DNA
replication is generally assumed to be minimal. In the S-phase of
the cell cycle, ribonucleotide reductase irreversibly converts
ribonucleoside diphosphates to deoxyribonucleoside diphosphates,
and subsequently, deoxyribonucleotides originating from de novo
sources proceed to become the predominant precursors to nDNA
replication. Thus, ribonucleotide affinities of these cytoplasmic
enzymes not only provide the ribonucleoside diphosphates for
ribonucleotide reduction but also ensure an adequate supply of
RNA substrates. The terminal kinase (NDPK) of the cytoplasmic
salvage pathway accepts both ribonucleoside and deoxyribonu-
cleoside diphosphates, and the products can then be appropriately
diverted for either RNA or DNA synthesis. Salvage enzymes of
thymidine metabolism fit nicely into such a model - examples
being the excellent kinetics of TK1 and TK2 with dT, and those of
cytoplasmic deoxythymidylate kinase (essential for both salvage
and de novo pathways of dTTP synthesis) with dTMP – since
thymidine is not an RNA substrate and because of the crucial
allosteric control exerted by thymidine nucleotides on ribonucle-
otide reductase [51] as well as feedback control on mitochondrial
TK2 [21]. Such similarities in the enzyme kinetics of the parallel
mitochondrial and cytoplasmic metabolisms lead to the question of
a ribonucleotide reductase connection to mitochondrial nucleotide
metabolism. Such a connection is hinted at by the data supporting
a connection between the mitochondrial dNTP pool and the
ribonucleotide reductase RRM2B [2,6]. There has been at least
one report of ribonucleotide reductase activity within the
mitochondrion [52], though this has never been confirmed as
far as we are aware of.
The Identity of the Imported Substrate and the
Contribution of Import in Quiescent Cells
Our simulations show that mitochondrial salvage is inadequate
to account for the observed replication time of ,1–2 hours in
cycling cells. It is likely that the deficit is supplied by import from
the cytoplasm. We propose that deoxyribonucleotide import into
the mitochondria not only does occur, but is in fact essential to
replicate and maintain mtDNA in cycling cells. Furthermore, in
our simulations, import at the monophosphate level was not able
to support mtDNA replication under the constraint of a replication
duration of 2 hours or less. Our observation that either dNDP or
dNTP transport are able to nearly identically support mtDNA
replication is due to the extremely fast kinetics of NME4, the
nucleoside diphosphate kinase. The fact that the NME4 kinetics
for the conversion of dNDP to dNTP are fast lends weight to the
hypothesis that transport occurs mainly at the dNDP level, and not
at the dNTP level which would bypass the NME4 activity.
Our results are not necessarily in disagreement with previous
reports that observed that supplementation with external dA and
dG or dAMP and dGMP rescued mtDNA depletion [3,28]. In
those cases, it was undetermined whether these externally supplied
substrates changed their phosphorylation level prior to or after
entering the mitochondria, or even the cell. In the study conducted
by Saada [28], in patient fibroblasts harboring DGUOK defects
while dGTP pools were reduced compared to controls, dATP
pools were only moderately affected. In this study when these
patient fibroblasts were given external supplementation of both
deoxyguanosine and deoxyadenosine, mitochondrial dGTP nota-
bly increased, while the increase in mitochondrial dATP was less
pronounced. Our observation on the inefficient kinetics of
DGUOK with dA is consistent with these findings. We are not
aware of any studies on the effects of pyrimidine supplementation
in TK2 deficiency.
We have chosen a somewhat arbitrary target replication time of
10 hours for the mtDNA in quiescent cells. It has been reported
that even in quiescent cells (rat hepatocytes), mitochondrial DNA
is subject to rapid turnover [53]. Moreover, it is plausible to
suspect that long replication durations might compromise the
integrity of either or both the template and the synthesis strand by
increasing the probability of damage to the exposed DNA or
unfaithful replication (deletions, frameshifting, etc). Therefore, it is
possible that the mtDNA replication time may be practically
constrained to a shorter duration than 10 hours. In that case
deoxynucleotide import could be essential even in quiescent cells.
support a replication rate of as long as 10 hours. Additional supply of dNs and dNMPs was insufficient to support a replication duration of 2 hours
indicating that additional dNDPs or dNTPs are essential. The results were essentially identical for supply of either dNDPs or dNTPs.
doi:10.1371/journal.pcbi.1002078.g006
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cells, a critically important gap in our knowledge since quiescent
cells are the most severely affected cells in most forms of
Mitochondrial DNA Depletion Syndromes (MDS).
Could there Be More than One Deoxynucleotide
Transporter?
The fact that clinical conditions arising from altered intra-
mitochondrial dNTP pools mostly manifest in postmitotic tissues is
consistent with our results. The possibility of there being more
than one deoxynucleotide transporter, say one for purine
deoxynucleotides and one for pyrimidine deoxynucleotides, might
explain why mutations in TK2 and DGUOK which are both
nucleoside kinases produce different phenotypes. It is plausible
that there exists more than one mitochondrial deoxynucleotide
transporter whose expression levels, possibly in conjunction with
other factors, contribute to tissue specificity of mtDNA depletion
syndromes. There have been reports [54,55] asserting a role of
PNC1 (pyrimidine nucleotide carrier encoded by solute carrier
family 25, member 33 or SLC25A33) in nucleotide import into
mitochondria as well as mitochondrial maintenance. PNC1 was
able to transport a variety of metabolites, including purine and
pyrimidine ribonucleotides and deoxyribonucleotides, with a
preference for UTP. Intra-mitochondrial UTP accumulation
decreased in response to siRNA-transfection against PNC1.
Mitochondrial ADP, ATP, and GTP levels were not significantly
altered but the effect on dNTPs was not investigated. Suppression
of PNC1 was associated with reduced mtDNA while overex-
pressed PNC1 was associated with increased mtDNA relative to
controls. Since UTP is a cofactor of the mitochondrial helicase
(PEO1 or twinkle), mtDNA levels might have been altered through
increased or decreased UTP [54]. It is also possible that these
consequences resulted from a lack of RNA primers or lack of
mtDNA precursors that might be substrates of PNC1. However,
PNC1 mRNA was undetectable in skeletal muscle [55], a tissue
that is a target of TK2 defects. Interestingly, ribonucleotide
reductase overexpression caused mtDNA depletion in skeletal
muscle of mice [56]. Also, per mg protein, PNC1 appeared to
transport roughly 1.5 times more UTP compared to dTTP, the
next most transported substrate. At this time, the role of PNC1 in
transporting deoxyribonucleotides for mtDNA synthesis is incon-
clusive. Import of radioactively labeled dTMP into mitochondria
has been observed [57]. However, it was also observed that a
fraction of the labeled dTMP was degraded as well as
phosphorylated in the growth medium, leading to the possibility
that the transport of phosphorylated states other than the
monophosphate may have occurred. A transport activity with
preference for dCTP has also been observed [58].
Tissue Specificity of mtDNA Depletion Syndromes
It has been proposed that low basal TK2 expression in muscle
renders the tissue vulnerable to TK2 defects, while overlapping
substrate specificity of cytosolic dCK prevents mtDNA depletion
from mutant DGUOK in tissues where dCK expression is high
[59]. While mtDNA defects that have a basis in mutated salvage
enzymes might conceivably be rescued by other factors such as
overlapping substrate specificity of cytoplasmic enzymes, this
hypothesis cannot account for phenotypes relating to POLG
defects. Importantly, the fact that phenotypes from mutations in
POLG are also tissue-specific and not systemic indicate that other
factors, such as rates of mtDNA turnover or energetic demand of
tissues might also be a factor in the basis of tissue selectivity. In a
recent review, Liya Wang discussed deoxynucleoside salvage
enzymes and their association with tissue specific phenotypes of
mtDNA depletion [60]. It was hypothesized that since mtDNA
turnover rates are different in different tissues and also because
dNTP pools show organ-specific differences, it would be expected
that the regulation of dNTP pools would also be different for
different tissues. Because both muscle and liver have high amounts
of mtDNA and also of mtDNA turnover, and since the dTTP pool
is lowest in muscle and the dGTP pool is smallest in liver, it was
proposed that these tissues would be especially vulnerable to
mutations in TK2 and DGUOK respectively. Other contributing
factors could include limiting RRM2B, thymidylate synthase, or
nucleotide transporter activity. In our opinion, it is probable that
there is more than one underlying principle that explains tissue
specificity – vulnerability of tissues to mutations might be from a
combination of various factors such as transcriptional compensa-
tion, turnover rates, energetic demand, etc and that different forms
of mtDNA depletion syndromes may trace their etiology to
different factors.
The Applicability of Our Results to Different Tissues and
Species
Based on their experiments with perfused rat heart, Morris et al
concluded that in isolated perfused heart, there is no de novo
synthesis of dNTPs [61], stressing the importance of TK2 in rat
heart. This could indicate that our observations on the inadequacy
of mitochondrial salvage enzymes may not hold across all tissue
types. It is also possible that the deoxyribonucleotide pools in rat
heart arose in part through salvage mediated by residual TK1
activity. In a recent report of a TK2
2/2 H126N knockin mouse
[62], the authors observed TK1 to be the main thymidine kinase
component in heart, compared to TK2 in the brain. In this mouse,
phenotypic manifestation of TK2 deficiency was related to TK1
down-regulation and transcriptional compensation. Although by
postnatal day 13 both brain and heart had suffered substantial
mtDNA depletion, in contrast to brain, heart was spared as
respiratory chain proteins were still at normal levels in this organ
when assayed at postnatal day 13. This could indicate a difference
in the importance of TK2 in the heart tissue of rats compared to
mice. A recent report claimed that a cytosolic localization of TK2
is present in many rat tissues [63]. For the knockin mouse [62], a
compensatory mechanism involving increased mtDNA transcrip-
tion through suppression of MTERF3 (mitochondrial transcription
termination factor 3) expression was implicated in alleviating some
of the effects of mtDNA depletion. It was unclear why dTTP but
not dCTP levels were affected and whether cytosolic ribonucle-
otide reduction had any influence in this observation. In humans,
even in quiescent patient fibroblasts with only 5–40% of residual
TK2 activity, mitochondrial and cytosolic dTTP pools were
unaltered [30]. This finding would be consistent with the
possibility that the activities of mitochondrial salvage enzymes
may not be strictly necessary even for quiescent cells. Alternatively,
it is also possible for there to be practical important differences
between species with regard to this metabolism. In their study of
the rat heart, Morris et al [61] noted that although known as a
substrate of TK2, dU was not converted to dUMP possibly due to
ENT1 nucleoside transporter not being localized to mitochondria
in rodents, unlike humans, suggesting that dU may not be
transported into the mitochondria in rodents. It has been noted
that genes involved in MDS (mtDNA depletion syndromes)
etiology are essential for life in mouse models [60]. However,
the severe phenotype of knock-out mice is not identical to the
phenotype in humans [64], although multi-organ phenotypes have
come to light in humans also [65]. This divergence could perhaps
be due to species differences or because of the complete absence of
enzyme activity in knock-out models [64].
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One limitation of modeling biochemical pathways is that kinetic
parameters as reported in the literature and obtained from
recombinant enzymes may not reflect the in situ reality, for
instance, if the enzyme conformation is unknowingly affected in
the in vitro analysis, or if the assay conditions do not represent the
cellular environment adequately. Similarly, we have relied on the
literature and our judgment for selecting appropriate concentra-
tions and enzyme copies within the mitochondrion. In our analysis
we have assumed a nucleoside concentration of 0.5 mM [33].
There have been reports of nucleoside concentrations of
approximately 50-fold lower [34]. Such lower concentrations
would have two effects on this analysis. First, the problems that we
point out concerning the function of the nucleoside kinases TK2
and DGUOK would be even worse with significantly lower
nucleoside concentrations. Second, there is a more subtle problem
that the enzyme kinetics for TK2 were measured at much higher
substrate concentrations (1 mM to more than 100 mM) [21]. If the
true substrate concentrations were on the order of 10 nM, then the
kinetics would have to be extrapolated to much lower concentra-
tions, which could introduce additional uncertainty in the kinetic
constants. Finally, our estimate of time taken to replicate mtDNA
(2 hours) comes from a study of mouse cells [45]. It is worth
mentioning that POLG kinetics suggest that polymerization itself is
capable of proceeding at a rate much faster than 2 hours [14]. A
more comprehensive investigation into mtDNA replication
durations in a variety of human cells and particularly in the cell
types affected by mtDNA depletion syndromes would thus be very
beneficial.
For simplicity, we assumed that only one mtDNA molecule is
replicating at any given time in a particular mitochondrion. If two
or more mtDNA molecules were replicating simultaneously, then
the deficit in the required dNTPs would be even larger than our
analysis indicates. It should also be noted that mitochondria are
very dynamic and undergo continuous fusion and fission.
However, the effects of fusion and fission on the mitochondrial
dNTP content would most likely average out. While fusion of two
mitochondria would result in a larger dNTP pool (measured as
number of molecules per organelle), fission would result in a
smaller dNTP pool.
Summary
Since the known elements of the mitochondrial salvage pathway
do not have sufficient enzyme kinetics to support mtDNA
replication in the observed duration of ,1–2 hours, then, an
alternative source of mtDNA precursors must be essential. Despite
the intensive focus of research on this pathway associated with
mitochondrial depletion syndromes, it seems likely that our
knowledge of mitochondrial nucleotide metabolism is still
incomplete and that this pathway might need to be considerably
expanded in the future to include new enzymes, mechanisms,
nucleotide transporters and modes of regulation.
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